Discovery of novel 2-substituted-4-(2-fluorophenoxy) pyridine derivatives possessing pyrazolone and triazole moieties as dual c-Met/VEGFR-2 receptor tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Discovery of novel 2-substituted-4-(2-fluorophenoxy) pyridine derivatives possessing pyrazolone and triazole moieties as dual c-Met/VEGFR-2 receptor tyrosine kinase inhibitors

Published:2017-06 Issue: Volume:72 Page:116-122
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Gu Weijie,Dai Yuxuan,Qiang Hao,Shi Wei,Liao Chen,Zhao Fangnuo,Huang Wenlong,Qian Hai

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference32 articles.

1. Global Statistics;Torre;CA Cancer J. Clin.,2012

2. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study;Bray;Lancet Oncol.,2012

3. Protein kinases-the major drug targets of the twenty-first century?;Cohen;Nat. Rev. Drug Disc.,2002

4. Role of tyrosine kinase inhibitors in cancer therapy;Arora;J. Pharmacol. Exp. Ther.,2005

5. Met, metastasis, motility and more;Birchmeier;Nat. Rev. Mol. Cell Biol.,2003

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the clinical trials;Biomedicine & Pharmacotherapy;2024-10

2. PTSA-induced synthesis, in silico and nano study of novel ethylquinolin–thiazolo–triazole in cervical cancer;Future Medicinal Chemistry;2024-04-10

3. Novel Triazole‐Containing “Dipeptides”: Synthesis, Molecular Docking and Analgesic Activity Studies;ChemBioChem;2024-03-27

4. Anticancer Drug Discovery By Structure-Based Repositioning Approach;Mini-Reviews in Medicinal Chemistry;2024-01

5. Discovery of new 1,3-diphenylurea appended aryl pyridine derivatives as apoptosis inducers through c-MET and VEGFR-2 inhibition: design, synthesis, in vivo and in silico studies;RSC Medicinal Chemistry;2024